Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Eli Lilly and Company LLY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
86/100
5/7 Pass
SharesGrow Intrinsic Value
$919.68
-0.3%
Analyst Price Target
$1,243.95
+34.8%
Metric TTM (2025-03 – 2025-12)
Revenue $65.18B
Gross Profit $54.62B
Gross Margin 83.8%
Operating Income $29.7B
Net Income $20.64B
Net Margin 31.7%
EPS (Diluted) $22.95

People Also View

JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 NVO
NVO
Novo Nordisk A/S
$39.32
+3.53%
 GILD
GILD
Gilead Sciences, Inc.
$140.45
+1.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message